GLO1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.058060E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.672400E-02
Normal-vs-Stage2
1.116470E-03
Normal-vs-Stage3
6.167700E-02
Normal-vs-Stage4
5.723400E-01
Stage1-vs-Stage2
4.302600E-01
Stage1-vs-Stage3
5.788600E-01
Stage1-vs-Stage4
8.175800E-02
Stage2-vs-Stage3
2.365000E-01
Stage2-vs-Stage4
4.470400E-02
Stage3-vs-Stage4
1.024790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.384000E-04
Normal-vs-AfricanAmerican
5.324200E-01
Normal-vs-Asian
5.028800E-01
Caucasian-vs-AfricanAmerican
3.685600E-01
Caucasian-vs-Asian
2.466200E-01
AfricanAmerican-vs-Asian
9.912400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.439540E-04
Normal-vs-Female
9.463300E-03
Male-vs-Female
5.043500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.788200E-02
Normal-vs-Age(41-60Yrs)
7.431900E-02
Normal-vs-Age(61-80Yrs)
9.83799999999535E-05
Normal-vs-Age(81-100Yrs)
1.164050E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.562100E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.510800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.748430E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.052180E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.823050E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.840800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.292490E-02
Normal-vs-Daily Drinker
3.729800E-02
Normal-vs-Weekly Drinker
4.550200E-02
Normal-vs-Occasional Drinker
8.263200E-01
Normal-vs-Social Drinker
2.353600E-02
Non Drinker-vs-Daily Drinker
1.670840E-01
Non Drinker-vs-Weekly Drinker
7.696000E-01
Non Drinker-vs-Occasional Drinker
5.817900E-02
Non Drinker-vs-Social Drinker
9.917000E-01
Daily Drinker-vs-Weekly Drinker
7.910300E-02
Daily Drinker-vs-Occasional Drinker
3.191000E-04
Daily Drinker-vs-Social Drinker
1.661800E-01
Weekly Drinker-vs-Occasional Drinker
1.198550E-01
Weekly Drinker-vs-Social Drinker
7.564000E-01
Occasional Drinker-vs-Social Drinker
6.398300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.590600E-01
Normal-vs-Grade 2
8.196000E-01
Normal-vs-Grade 3
8.375200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.017630E-02
Grade 1-vs-Grade 3
6.535700E-02
Grade 1-vs-Grade 4
9.590600E-01
Grade 2-vs-Grade 3
7.061800E-01
Grade 2-vs-Grade 4
8.196000E-01
Grade 3-vs-Grade 4
8.375200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.96469999999405E-05
Normal-vs-NonDiabetic
1.601830E-03
Diabetic-vs-NonDiabetic
1.025240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.115600E-02
Normal-vs-NoPancreatitis
9.627300E-04
Pancreatitis-vs-NoPancreatitis
1.351430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.323860E-03
Normal-vs-N1
6.844300E-04
N0-vs-N1
8.519200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.961600E-01
Normal-vs-TP53-NonMutant
4.144000E-01
TP53-Mutant-vs-TP53-NonMutant
5.700400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
